| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |